ISRG vs WST
Intuitive Surgical and West Pharmaceutical Services, both Healthcare
Intuitive Surgical is the larger company at $144B against $23B. On trailing earnings WST is the cheaper of the two at a P/E of 46.9 against 48.6, a gap that is only a bargain if the two are growing at similar rates. Over the past year WST returned +44% against -2.7% for ISRG. The RyuScore puts ISRG ahead, 63 against 62 out of 100.
| Figure | ISRG | WST |
|---|---|---|
| Last close | $424 | $366 |
| Market cap | $144B | $23B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 48.6 | 46.9 |
| Dividend yield | n/a | 0.2% |
| 1-year return | -2.7% | +44% |
| 5-year return | +24% | -16% |
| RyuScoresector-relative, 1–10 | 63/100 | 62/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Intuitive Surgical
Revenue of $2.9B in Q2 2026, net income $818M. Its largest reported line is Instrumentsand Accessories, 49% of the disclosed total.
West Pharmaceutical Services
Revenue of $872M in Q2 2026, net income $154M. Its largest reported line is Proprietary Products, 83% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.